This report contains market size and forecasts of Daclatasvir in global, including the following market information:
Global Daclatasvir Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Daclatasvir Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Daclatasvir companies in 2021 (%)
The global Daclatasvir market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
30mg Tables Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Daclatasvir include Bristol-Myers Squibb, Natco Pharma, Zydus Cadila, Hetero Drugs, Dr Reddy's Laboratories, Cipla, Mylan, Abbott and Emcure Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Daclatasvir manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Daclatasvir Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Daclatasvir Market Segment Percentages, by Type, 2021 (%)
30mg Tables
60mg Tables
Global Daclatasvir Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Daclatasvir Market Segment Percentages, by Application, 2021 (%)
Hepatitis C Virus (HCV) Genotype 1
Hepatitis C Virus (HCV) Genotype 3
Hepatitis C Virus (HCV) Genotype 4
Global Daclatasvir Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Daclatasvir Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Daclatasvir revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Daclatasvir revenues share in global market, 2021 (%)
Key companies Daclatasvir sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Daclatasvir sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Natco Pharma
Zydus Cadila
Hetero Drugs
Dr Reddy's Laboratories
Cipla
Mylan
Abbott
Emcure Pharmaceuticals
Torrent Pharmaceuticals
Biocon